Muromonab
Catalogue number:
HY-P99152-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
CD3;IFNAR;Interleukin Related
Alternative Names:
Muromanab-CD3
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Muromonab (Muromonab-CD3; OKT3) is a mouse monoclonal antibody targeting the CD3 antigen. Muromonab specifically binds to the CD3 antigen on the surface of human and higher primate T cells. Muromonab blocks the function of T cell receptors to recognize foreign antigens and inhibits T cell-mediated immune responses, including cell-mediated lymphocyte lysis and T cell proliferation responses. Muromonab can be used to study acute kidney, liver, heart and combined kidney-pancreas transplant rejection, and can also be used to study graft-versus-host disease in bone marrow transplant patients[1][2][3][4][5].